Sugimoto Yoshikazu | Division Of Chemotherapy Keio University
スポンサーリンク
概要
関連著者
-
Sugimoto Yoshikazu
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Sugimoto Yoshikazu
Division Of Chemotherapy Keio University
-
Sugimoto Yoshikazu
Division Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Mitsuhashi Junko
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Katayama Kazuhiro
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Noguchi Kohji
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Katayama Kazuhiro
Division Of Cardiology Department Of Medicine School Of Medicine University Of California
-
Sugimoto Yoshikazu
Department Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
KATAYAMA KAZUHIRO
Division of cardiology, Department of Medicine, School of Medicine, University of California
-
KAWAHARA Haruka
Division of Chemotherapy, Faculty of Pharmacy, Keio University
-
Kawahara Haruka
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Akiyama Shin-ichi
Department Of Molecular Oncology Graduate School Of Medical And Dental Sciences Kagoshima University
-
Akiyama Shin-ichi
鹿児島大学 医歯学総合研究科分子腫瘍学
-
Akiyama Shin-ichi
大阪大学 薬研究
-
Akiyama S
Department Of Molecular Oncology Graduate School Of Medical And Dental Sciences Kagoshima University
-
Akiyama Shin-ichi
Department Of Cancer Chemotherapy Institute For Cancer Research
-
FURUKAWA Tatsuhiko
Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Kagoshima Universi
-
REN Xiao-Qin
Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Kagoshima Universi
-
AOKI Shunji
Graduate School of Pharmaceutical Sciences, Osaka University
-
KOBAYASHI Motomasa
Graduate School of Pharmaceutical Sciences, Osaka University
-
SUMIZAWA Tomoyuki
Department of Molecular Oncology, Field of Oncology, Course of Advanced Therapeutics, Graduate Schoo
-
HARAGUCHI Misako
Department of Molecular Oncology, Field of Oncology, Course of Advanced Therapeutics, Graduate Schoo
-
MUKAI Motoi
Department of Cancer Chemotherapy, Institute for Cancer Research Kagoshima University
-
CHE Xiao-Fang
Department of Cancer Chemotherapy, Institute for Cancer Research Kagoshima University
-
SUGIMOTO Yoshikazu
Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Researc
-
TAKAMATSU Hideo
Department of Pediatric Surgery, Faculty of Medicine, Kagoshima University
-
Takahashi Shunji
Cancer Inst. Hospital Tokyo Jpn
-
Aoki S
Graduate School Of Pharmaceutical Sciences Osaka University
-
Aoki Shunji
Graduate School Of Pharmaceutical Sciences Osaka University
-
Mukai Motoi
Department Of Cancer Chemotherapy Institute For Cancer Research Kagoshima University
-
Ren Xiao-qin
Department Of Molecular Oncology Graduate School Of Medical And Dental Sciences Kagoshima University
-
Che Xiao-fang
Department Of Cancer Chemotherapy Institute For Cancer Research Kagoshima University
-
Akiyama Shin-ichi
Department Of Cancer Chemotherapy Institute For Cancer Research Faculty Of Medicine Kagoshima Univer
-
TSUKAHARA Satomi
Division of Gene Therapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
SUGIMOTO Yoshikazu
Department of Gene Therapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Kobayashi M
Fujisawa Pharmaceutical Co. Ltd. :(peresent Address)fujisawa Research Insitute Of America Inc. North
-
Takamatsu Hideo
Department Of Cytochemistry Chest Disease Research Institute Kyoto University
-
Haraguchi Misako
Department Of Cancer Chemotherapy Institute For Cancer Research Kagoshima University
-
Sumizawa Tomoyuki
Department Of Environmental Toxicology Institute Of Industrial Ecological Sciences University Of Occ
-
Kobayashi M
Faculty Of Pharmaceutical Sciences Osaka University
-
Kobayashi Masao
Pharmaceutical Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Tatsuhiko Furukawa
Department Of Molecular Oncology Graduate School Of Medical And Dental Sciences Kagoshima University
-
Kobayashi M
Graduate School Of Pharmaceutical Sciences Osaka University
-
Takahashi Shunji
Department Of Oncology And Hematology Cancer Institute Hospital
-
Bando Toshikazu
Department Of Chemistry Graduate School Of Science Kyoto University
-
Futagawa Toshitaka
Department Of Clinical Pharmacy And Pharmacology Graduate School Of Medical And Dental Sciences Kago
-
小林 資正
Graduate School Of Pharmaceutical Sciences Osaka University
-
Katayama Kazuhiro
Department Of Gastroenterology And Hepatology Osaka Koseinenkin Hospital
-
Kobayashi Motomasa
Graduate School Of Pharmaceutical Sciences Osaka Univ.
-
Minoshima Masafumi
Department Of Chemistry Graduate School Of Science Kyoto University
-
Tsukahara Satomi
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Kawaguchi M
Graduate School Of Pharmaceutical Sciences Osaka University
-
Sugimoto Yoshikazu
Division Of Molecular Biotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Tsukahara Satomi
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
MUTOH Kazuyoshi
Department of Chemotherapy, Kyoritsu University of Pharmacy
-
MITSUHASHI Junko
Department of Chemotherapy, Kyoritsu University of Pharmacy
-
SHIGETA Junichi
Division of Chemotherapy, Faculty of Pharmacy, Keio University
-
KAJI Airi
Division of Chemotherapy, Graduate School of Pharmaceutical Sciences, Keio University
-
Takamatsu Hideo
Department Of Pediatric Surgery Faculty Of Medicine Kagoshima University
-
Kaji Airi
Division Of Chemotherapy Graduate School Of Pharmaceutical Sciences Keio University
-
Mutoh Kazuyoshi
Department Of Chemotherapy Kyoritsu University Of Pharmacy
-
Shigeta Junichi
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Futagawa Toshitaka
Department Of Clinical Pharmacy And Pharmacology Graduate School Of Medical And Dental Sciences Kago
-
Sugiyama Hiroshi
Department Of Chemistry Faculty Of Science
-
YASUDA Ai
Division of Chemotherapy, Keio University
-
KASHIWAZAKI Gengo
Department of Chemistry, Kyoto University
-
KANDA Teru
Division of Virology, Aichi Cancer Center Research Institute
-
Yasuda Ai
Division Of Chemotherapy Keio University
-
Kanda Teru
Division Of Virology Aichi Cancer Center Research Institute
-
Kashiwazaki Gengo
Department Of Chemistry Kyoto University
-
Che Xiao-fang
Department Of Biochemistry Tokyo Medical University
-
Sugiyama Hiroshi
Department Of Chemistry Kyoto University
-
Sumizawa Tomoyuki
Department Of Domestic Science Kagoshima Women's Junior College
-
Aoki Shunji
Graduate School Of Industrial Engineering Tokai University
-
SUGIMOTO Yoshikazu
Department of Chemotherapy, Faculty of Pharmacy, Keio University
著作論文
- Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells
- Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells
- BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization
- Pharmacological interaction with sunitinib is abolished by a germ-line mutation (1291T>C) of BCRP/ABCG2 gene
- Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib
- DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization